ArticleACS medicinal chemistry letters2026

Discovery of BMS-159, an Orally Active Imidazotriazine Pan-CK2 Inhibitor for the Treatment of Cancer.

Christine M Tarby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.